Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL	Title	Category	Date	Recent Activity
https://sentinelinitiative.org/methods-data-tools/sentinel-common-data-model/sentinel-common-data-model	Sentinel Common Data Model	Methods, Data, & Tools	12/08/2020	Sentinel Common Data Model Methods, Data, & Tools 12/08/2020
https://sentinelinitiative.org/assessments/drugs/assessing-arias-ability-evaluate-safety-concern/brexafemme-ibrexafungerp	Assessment of ARIA Sufficiency: Brexafemme (ibrexafungerp)	Assessments	04/08/2021	Assessment of ARIA Sufficiency: Brexafemme (ibrexafungerp) Assessments 04/08/2021
https://sentinelinitiative.org/assessments/drugs/assessing-arias-ability-evaluate-safety-concern/nextstellis-drospirenone-and	Assessment of ARIA Sufficiency: Nextstellis (drospirenone and estetrol)	Assessments	04/08/2021	Assessment of ARIA Sufficiency: Nextstellis (drospirenone and estetrol) Assessments 04/08/2021
https://sentinelinitiative.org/assessments/drugs/individual-drug-queries/duration-follow-new-molecular-entities-approved-2016	Duration of Follow Up for New Molecular Entities Approved in 2016	Assessments	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2016 Assessments 04/16/2021
https://sentinelinitiative.org/assessments/drugs/individual-drug-queries/duration-follow-new-molecular-entities-approved-2014-and	Duration of Follow Up for New Molecular Entities Approved in 2014 and 2015	Assessments	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2014 and 2015 Assessments 04/16/2021
https://sentinelinitiative.org/assessments/drugs/individual-drug-queries/duration-follow-new-molecular-entities-approved-2010-2012	Duration of Follow Up for New Molecular Entities Approved in 2010, 2012, and 2013	Assessments	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2010, 2012, and 2013 Assessments 04/16/2021
https://sentinelinitiative.org/assessments/drugs/individual-drug-queries/duration-follow-new-molecular-entities-approved-2008-and	Duration of Follow Up for New Molecular Entities Approved in 2008 and 2009	Assessments	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2008 and 2009 Assessments 04/16/2021
https://sentinelinitiative.org/assessments/drugs/individual-drug-queries/duration-follow-new-molecular-entities-approved-2005-2006	Duration of Follow Up for New Molecular Entities Approved in 2005, 2006, and 2007	Assessments	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2005, 2006, and 2007 Assessments 04/16/2021
https://sentinelinitiative.org/assessments/drugs/individual-drug-queries/duration-follow-new-molecular-entities-approved-2011	Duration of Follow Up for New Molecular Entities Approved in 2011	Assessments	04/16/2021	Duration of Follow Up for New Molecular Entities Approved in 2011 Assessments 04/16/2021
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/measure-what-you-treasure-challenges-and-opportunities	Measure What You Treasure - The Challenges and Opportunities of Collecting Real World Endpoints	Sentinel Initiative Events	06/22/2021	Measure What You Treasure - The Challenges and Opportunities of Collecting Real World Endpoints Sentinel Initiative Events 06/22/2021
https://sentinelinitiative.org/news-events/publications-presentations/using-prenatal-tests-estimate-pregnancy-start-health-0	Using Prenatal Tests to Estimate Pregnancy Start in Health Insurance Claims Data	Publications and Presentations	06/29/2021	Using Prenatal Tests to Estimate Pregnancy Start in Health Insurance Claims Data Publications and Presentations 06/29/2021
https://sentinelinitiative.org/engage-sentinel/quarterly-newsletter	Quarterly Newsletter	Spotlight	07/01/2021	Quarterly Newsletter Spotlight 07/01/2021
https://sentinelinitiative.org/assessments/drugs/assessing-arias-ability-evaluate-safety-concern/vyepti-eptinezumab	Assessment of ARIA Sufficiency: Vyepti (eptinezumab)	Assessments	07/01/2021	Assessment of ARIA Sufficiency: Vyepti (eptinezumab) Assessments 07/01/2021
https://sentinelinitiative.org/news-events/publications-presentations/use-mobile-app-capture-supplemental-health-information	Use of a Mobile App to Capture Supplemental Health Information During Pregnancy: Implications for Clinical Research	Publications and Presentations	07/03/2021	Use of a Mobile App to Capture Supplemental Health Information During Pregnancy: Implications for Clinical Research Publications and Presentations 07/03/2021
https://sentinelinitiative.org/methods-data-tools/methods/representation-unstructured-data-across-common-data-models	Representation of Unstructured Data Across Common Data Models	Methods, Data, & Tools	07/14/2021	Representation of Unstructured Data Across Common Data Models Methods, Data, & Tools 07/14/2021
https://sentinelinitiative.org/methods-data-tools/methods/treescan-pregnancy	TreeScan in Pregnancy	Methods, Data, & Tools	07/14/2021	TreeScan in Pregnancy Methods, Data, & Tools 07/14/2021
https://sentinelinitiative.org/methods-data-tools/methods/using-unsupervised-learning-harmonize-data-across-data-systems	Using Unsupervised Learning to Harmonize Data Across Data Systems	Methods, Data, & Tools	07/28/2021	Using Unsupervised Learning to Harmonize Data Across Data Systems Methods, Data, & Tools 07/28/2021
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/natural-language-processing-ehr-based-pharmacovigilance	Natural Language Processing for EHR-based Pharmacovigilance: Current Progress and Future Directions	Sentinel Initiative Events	07/29/2021	Natural Language Processing for EHR-based Pharmacovigilance: Current Progress and Future Directions Sentinel Initiative Events 07/29/2021
https://sentinelinitiative.org/assessments/vaccines-blood-biologics/fungal-keratitis-following-keratoplasty-procedures-descriptive	Fungal Keratitis following Keratoplasty Procedures: A Descriptive Analysis	Modular Programs	07/29/2021	Fungal Keratitis following Keratoplasty Procedures: A Descriptive Analysis Modular Programs 07/29/2021
https://sentinelinitiative.org/methods-data-tools/routine-querying-tools/routine-querying-system	Routine Querying System	Methods, Data, & Tools	08/02/2021	Routine Querying System Methods, Data, & Tools 08/02/2021
https://sentinelinitiative.org/news-events/publications-presentations/who-gets-treated-influenza-surveillance-study-us-food-and	Who Gets Treated for Influenza: A Surveillance Study From the US Food and Drug Administration’s Sentinel System	Publications and Presentations	08/05/2021	Who Gets Treated for Influenza: A Surveillance Study From the US Food and Drug Administration’s Sentinel System Publications and Presentations 08/05/2021
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/adaptive-validation-designs-premise-and-methods	Adaptive Validation Designs: Premise and Methods	Sentinel Initiative Events	08/09/2021	Adaptive Validation Designs: Premise and Methods Sentinel Initiative Events 08/09/2021
https://sentinelinitiative.org/assessments/drugs/individual-drug-queries/brand-and-generic-tacrolimus-use-following-kidney-heart	Brand and Generic Tacrolimus Use following Kidney, Heart, and Liver Transplants: A Descriptive Analysis	Modular Programs	08/11/2021	Brand and Generic Tacrolimus Use following Kidney, Heart, and Liver Transplants: A Descriptive Analysis Modular Programs 08/11/2021
https://sentinelinitiative.org/assessments/drugs/individual-drug-queries/duration-follow-new-molecular-entities-approved-2017	Duration of Follow Up for New Molecular Entities Approved in 2017	Modular Programs	08/13/2021	Duration of Follow Up for New Molecular Entities Approved in 2017 Modular Programs 08/13/2021
https://sentinelinitiative.org/methods-data-tools/methods/develop-common-protocol-data-quality-metrics-electronic-health-records	Develop a Common Protocol for Data Quality Metrics in Electronic Health Records	Methods, Data, & Tools	08/18/2021	Develop a Common Protocol for Data Quality Metrics in Electronic Health Records Methods, Data, & Tools 08/18/2021
https://sentinelinitiative.org/assessments/drugs/individual-drug-queries/utilization-drugs-approved-risk-evaluation-and-mitigation	Utilization of Drugs with Approved Risk Evaluation and Mitigation Strategies (REMS) that Employ Elements to Assure Safe Use (ETASU)	Assessments	08/23/2021	Utilization of Drugs with Approved Risk Evaluation and Mitigation Strategies (REMS) that Employ Elements to Assure Safe Use (ETASU) Assessments 08/23/2021
https://sentinelinitiative.org/news-events/publications-presentations/use-mobile-app-capture-supplemental-health-information-0	Use of a Mobile App to Capture Supplemental Health Information During Pregnancy: Implications for Clinical Research	Publications and Presentations	08/23/2021	Use of a Mobile App to Capture Supplemental Health Information During Pregnancy: Implications for Clinical Research Publications and Presentations 08/23/2021
https://sentinelinitiative.org/news-events/publications-presentations/statistical-power-use-tree-based-scan-statistics	Statistical Power for Use of Tree-Based Scan Statistics for Surveillance of Infant Outcomes Following Maternal Perinatal Medication Use	Publications and Presentations	08/23/2021	Statistical Power for Use of Tree-Based Scan Statistics for Surveillance of Infant Outcomes Following Maternal Perinatal Medication Use Publications and Presentations 08/23/2021
https://sentinelinitiative.org/news-events/publications-presentations/use-tree-based-scan-statistics-surveillance-infant-outcomes	Use of Tree-Based Scan Statistics for Surveillance of Infant Outcomes Following Maternal Perinatal Medication Use: A Propensity Score Matched Case Study	Publications and Presentations	08/23/2021	Use of Tree-Based Scan Statistics for Surveillance of Infant Outcomes Following Maternal Perinatal Medication Use: A Propensity Score Matched Case Study Publications and Presentations 08/23/2021
https://sentinelinitiative.org/news-events/publications-presentations/post-keratoplasty-fungal-keratitis-sentinel-distributed	Post-Keratoplasty Fungal Keratitis in the Sentinel Distributed Database: Prevalence and Time Trends	Publications and Presentations	08/23/2021	Post-Keratoplasty Fungal Keratitis in the Sentinel Distributed Database: Prevalence and Time Trends Publications and Presentations 08/23/2021
https://sentinelinitiative.org/news-events/publications-presentations/how-under-coded-pediatric-hypertension-comparison-claims-and	How Under-Coded is Pediatric Hypertension?: Comparison of Claims and Electronic Health Record (EHR) Data	Publications and Presentations	08/23/2021	How Under-Coded is Pediatric Hypertension?: Comparison of Claims and Electronic Health Record (EHR) Data Publications and Presentations 08/23/2021
https://sentinelinitiative.org/news-events/publications-presentations/pregnancy-women-heart-failure-cross-sectional-study-sentinel	Pregnancy in Women with Heart Failure: A Cross-Sectional Study in the Sentinel Distributed Database	Publications and Presentations	08/23/2021	Pregnancy in Women with Heart Failure: A Cross-Sectional Study in the Sentinel Distributed Database Publications and Presentations 08/23/2021
https://sentinelinitiative.org/news-events/publications-presentations/prescription-medication-use-and-baseline-health-status-women	Prescription Medication Use and Baseline Health Status of Women with Live Birth Deliveries in a National Data Network: The Sentinel Distributed Database Mother-Infant Linkage Table	Publications and Presentations	08/23/2021	Prescription Medication Use and Baseline Health Status of Women with Live Birth Deliveries in a National Data Network: The Sentinel Distributed Database Mother-Infant Linkage Table Publications and Presentations 08/23/2021
https://sentinelinitiative.org/news-events/meetings-workshops-trainings/37th-international-conference-pharmacoepidemiology-and	37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management	Sentinel Initiative Events	08/23/2021	37th International Conference on Pharmacoepidemiology and Therapeutic Risk Management Sentinel Initiative Events 08/23/2021
https://sentinelinitiative.org/news-events/publications-presentations/comparing-outcomes-trial-eligible-vs-real-world-covid-19	Comparing Outcomes in Trial-Eligible vs Real-World COVID-19 Patients: The Case of Invasive Mechanical Ventilation	Publications and Presentations	08/23/2021	Comparing Outcomes in Trial-Eligible vs Real-World COVID-19 Patients: The Case of Invasive Mechanical Ventilation Publications and Presentations 08/23/2021
https://sentinelinitiative.org/news-events/publications-presentations/early-uptake-new-molecular-entities-approved-2017-multisite	Early Uptake of New Molecular Entities Approved in 2017 in a Multisite National US Healthcare Data Network	Publications and Presentations	08/23/2021	Early Uptake of New Molecular Entities Approved in 2017 in a Multisite National US Healthcare Data Network Publications and Presentations 08/23/2021
https://sentinelinitiative.org/news-events/publications-presentations/outpatient-identified-covid-19-and-subsequent-hospitalized	Outpatient-Identified COVID-19 and Subsequent Hospitalized Thrombotic Events	Publications and Presentations	08/23/2021	Outpatient-Identified COVID-19 and Subsequent Hospitalized Thrombotic Events Publications and Presentations 08/23/2021
https://sentinelinitiative.org/methods-data-tools/methods/longitudinal-trends-incident-and-prevalent-use-long-acting-beta-2	Longitudinal Trends in Incident and Prevalent use of Long-Acting Beta-2 Agonists: An Interrupted Time Series Analysis	Methods, Data, & Tools	08/24/2021	Longitudinal Trends in Incident and Prevalent use of Long-Acting Beta-2 Agonists: An Interrupted Time Series Analysis Methods, Data, & Tools 08/24/2021
https://sentinelinitiative.org/news-events/publications-presentations/new-frontiers-computable-phenotyping-medical-product-safety	New Frontiers in Computable Phenotyping for Medical Product Safety Evaluation	Publications and Presentations	08/24/2021	New Frontiers in Computable Phenotyping for Medical Product Safety Evaluation Publications and Presentations 08/24/2021
https://sentinelinitiative.org/news-events/publications-presentations/no-differential-risk-cutaneous-small-vessel-vasculitis-oral	No Differential Risk of Cutaneous Small Vessel Vasculitis with Oral Anticoagulant Use Among Patients with Atrial Fibrillation	Publications and Presentations	08/24/2021	No Differential Risk of Cutaneous Small Vessel Vasculitis with Oral Anticoagulant Use Among Patients with Atrial Fibrillation Publications and Presentations 08/24/2021